Mariano Garcia-Blanco

Dr. Mariano Garcia-Blanco

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Antiviral Research
Verified
Journal Article
Closed access
SWScott Weaver
Scott Weaver
FCFederico Costa
Federico Costa
MGMariano Garcia-Blanco
Mariano Garcia-Blanco
AKAlbert I. Ko
Albert I. Ko
GRGuilherme Ribeiro
Guilherme Ribeiro
NVNikos Vasilakis
Nikos Vasilakis

1 August 2016 in Cell Host & Microbe
Verified
Journal Article
Closed access
NBNicholas J. Barrows
Nicholas J. Barrows
RCRafael K Campos
Rafael K Campos
SPSteven T. Powell
Steven T. Powell
KPK. Reddisiva Prasanth
K. Reddisiva Prasanth
GSGeraldine Schott-Lerner
Geraldine Schott-Lerner
MGMariano Garcia-Blanco
Mariano Garcia-Blanco

13 April 2018 in Chemical Reviews
Verified
Journal Article
Closed access
NBNicholas J. Barrows
Nicholas J. Barrows
RCRafael K Campos
Rafael K Campos
KLKuo-Chieh Liao
Kuo-Chieh Liao
KPK. Reddisiva Prasanth
K. Reddisiva Prasanth
RSRuben Soto-Acosta
Ruben Soto-Acosta
MGMariano Garcia-Blanco
Mariano Garcia-Blanco

13 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
AMAntonio E. Muruato
Antonio E. Muruato
CFCamila R. Fontes-Garfias
Camila R. Fontes-Garfias
PRPing Ren
Ping Ren
MGMariano Garcia-Blanco
Mariano Garcia-Blanco
VMVineet D. Menachery
Vineet D. Menachery
PSPei-Yong Shi
Pei-Yong Shi
Virus neutralization remains the gold standard for determining antibody efficacy. Therefore, a high-throughput assay to measure SARS-CoV-2 neutralizing antibodies is urgently needed for COVID-19 serodiagnosis, convalescent plasma therapy, and vaccine development. Here, we report on a fluorescence-based SARS-CoV-2 neutralization assay that detects SARS-CoV-2 neutralizing antibodies in COVID-19 patient specimens and yields comparable results to plaque reduction neutralizing assay, the gold standard of serological testing. The fluorescence-based neutralization assay is specific to measure COVID-19 neutralizing antibodies without cross reacting with patient specimens with other viral, bacterial, or parasitic infections. Collectively, our approach offers a rapid platform that can be scaled to screen people for antibody protection from COVID-19, a key parameter necessary to safely reopen local communities.

3 July 2014 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
KBKatell Bidet
Katell Bidet
DDDhivya Dadlani
Dhivya Dadlani
MGMariano Garcia-Blanco
Mariano Garcia-Blanco
Viral RNA-host protein interactions are critical for replication of flaviviruses, a genus of positive-strand RNA viruses comprising major vector-borne human pathogens including dengue viruses (DENV). We examined three conserved host RNA-binding proteins (RBPs) G3BP1, G3BP2 and CAPRIN1 in dengue virus (DENV-2) infection and found them to be novel regulators of the interferon (IFN) response against DENV-2. The three RBPs were required for the accumulation of the protein products of several interferon stimulated genes (ISGs), and for efficient translation of PKR and IFITM2 mRNAs. This identifies G3BP1, G3BP2 and CAPRIN1 as novel regulators of the antiviral state. Their antiviral activity was antagonized by the abundant DENV-2 non-coding subgenomic flaviviral RNA (sfRNA), which bound to G3BP1, G3BP2 and CAPRIN1, inhibited their activity and lead to profound inhibition of ISG mRNA translation. This work describes a new and unexpected level of regulation for interferon stimulated gene expression and presents the first mechanism of action for an sfRNA as a molecular sponge of anti-viral effectors in human cells. Dengue virus is the most prevalent arbovirus in the world and an increasingly significant public health problem. Development of vaccines and therapeutics has been slowed by poor understanding of viral pathogenesis. Especially, how the virus subverts the host interferon response, a powerful branch of the innate immune system remains the subject of debate and great interest. Dengue virus produces large quantities of a non-coding, highly structured viral RNA, termed sfRNA, whose function in viral replication is elusive but has been linked in related viruses to inhibition of the interferon response. Nonetheless the mechanisms involved are yet to be characterized. Here, we show that dengue virus 2 sfRNA targets and antagonizes a set of host RNA-binding proteins G3BP1, G3BP2 and CAPRIN1, to interfere with translation of antiviral interferon-stimulated mRNAs. This activity impairs establishment of the antiviral state, allowing the virus to replicate and evade the interferon response. While this particular mechanism was not conserved among other flaviviruses, we believe it is highly relevant for dengue virus 2 replication and pathogenesis. Taken together, our results highlight both new layers of complexity in the regulation of the innate immune response, as well as the diversity of strategies flaviviruses employ to counteract it.

6 June 2017 in Viruses
Verified
Journal Article
Open access
PDF file
WNWyching Ng
Wyching Ng
RSRuben Soto-Acosta
Ruben Soto-Acosta
SBShelton Bradrick
Shelton Bradrick
MGMariano Garcia-Blanco
Mariano Garcia-Blanco
EOEng Eong Ooi
Eng Eong Ooi
Flaviviruses are enveloped arthropod-borne viruses with a single-stranded, positive-sense RNA genome that can cause serious illness in humans and animals. The 11 kb 5′ capped RNA genome consists of a single open reading frame (ORF), and is flanked by 5′ and 3′ untranslated regions (UTR). The ORF is a polyprotein that is processed into three structural and seven non-structural proteins. The UTRs have been shown to be important for viral replication and immune modulation. Both of these regions consist of elements that are essential for genome cyclization, resulting in initiation of RNA synthesis. Genome mutation studies have been employed to investigate each component of the essential elements to show the necessity of each component and its role in viral RNA replication and growth. Furthermore, the highly structured 3′UTR is responsible for the generation of subgenomic flavivirus RNA (sfRNA) that helps the virus evade host immune response, thereby affecting viral pathogenesis. In addition, changes within the 3′UTR have been shown to affect transmissibility between vector and host, which can influence the development of vaccines.